Come up with a name for your new list and we'll add to it:
Ra Pharmaceuticals raised a round of funding on February 21, 2012. Investors include
Massachusetts Life Sciences Center.
Ra Pharma combines novel insights into innate immunity with leadership in macrocycle technology to transform the lives of patients with life-threatening disorders. The company's proprietary peptide ch…